N-(4-Ethynylphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide

95%

Reagent Code: #215850
fingerprint
CAS Number 1380716-06-2

science Other reagents with same CAS 1380716-06-2

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 290.32 g/mol
Formula C₁₇H₁₄N₄O
badge Registry Numbers
MDL Number MFCD23134328
inventory_2 Storage & Handling
Density 1.20±0.1 g/cm3(Predicted)
Storage 2-8°C, sealed, dry

description Product Description

Used in pharmaceutical research as a potent and selective inhibitor of phosphodiesterase 2 (PDE2), this compound is investigated for its potential in treating cognitive and neurodegenerative disorders such as Alzheimer's disease and schizophrenia.

Its ability to cross the blood-brain barrier enhances its effectiveness in modulating intracellular cAMP and cGMP levels in the central nervous system, supporting synaptic plasticity and memory formation.

It serves as a valuable tool compound in preclinical studies exploring PDE2 inhibition as a therapeutic strategy.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 25mg
10-20 days ฿11,860.00
inventory 100mg
10-20 days ฿34,150.00
inventory 250mg
10-20 days ฿51,220.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
N-(4-Ethynylphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide
No image available

Used in pharmaceutical research as a potent and selective inhibitor of phosphodiesterase 2 (PDE2), this compound is investigated for its potential in treating cognitive and neurodegenerative disorders such as Alzheimer's disease and schizophrenia.

Its ability to cross the blood-brain barrier enhances its effectiveness in modulating intracellular cAMP and cGMP levels in the central nervous system, supporting synaptic plasticity and memory formation.

It serves as a valuable tool compound in pre

Used in pharmaceutical research as a potent and selective inhibitor of phosphodiesterase 2 (PDE2), this compound is investigated for its potential in treating cognitive and neurodegenerative disorders such as Alzheimer's disease and schizophrenia.

Its ability to cross the blood-brain barrier enhances its effectiveness in modulating intracellular cAMP and cGMP levels in the central nervous system, supporting synaptic plasticity and memory formation.

It serves as a valuable tool compound in preclinical studies exploring PDE2 inhibition as a therapeutic strategy.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...